The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Dermatology is the branch of medicine dealing with the skin, nails, hair and its diseases.Dermatological products help to deal with these diseases.
The global Dermatological Products market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dermatological Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dermatological Products is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Dermatological Products in Male is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Dermatological Products include Johnson & Johnson, GSK, Pfizer, AbbVie, Bayer, Merck, Reckitt Benckiser, Taisho Pharmaceutical and Perrigo, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dermatological Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatological Products.
Report Scope
The Dermatological Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dermatological Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dermatological Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Johnson & Johnson
- GSK
- Pfizer
- AbbVie
- Bayer
- Merck
- Reckitt Benckiser
- Taisho Pharmaceutical
- Perrigo
- Ikeda Mohando
- DermaPharm A/S
- LEO Pharma
Segment by Type
- Oil/Liquid
- Ointment/Cream/Gel
- Powder
- Others
Segment by Application
- Male
- Female
- Kids
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Dermatological Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermatological Products Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oil/Liquid
1.2.3 Ointment/Cream/Gel
1.2.4 Powder
1.2.5 Others
1.3 Market by Application
1.3.1 Global Dermatological Products Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Male
1.3.3 Female
1.3.4 Kids
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dermatological Products Market Perspective (2019-2030)
2.2 Dermatological Products Growth Trends by Region
2.2.1 Global Dermatological Products Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Dermatological Products Historic Market Size by Region (2019-2024)
2.2.3 Dermatological Products Forecasted Market Size by Region (2025-2030)
2.3 Dermatological Products Market Dynamics
2.3.1 Dermatological Products Industry Trends
2.3.2 Dermatological Products Market Drivers
2.3.3 Dermatological Products Market Challenges
2.3.4 Dermatological Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dermatological Products Players by Revenue
3.1.1 Global Top Dermatological Products Players by Revenue (2019-2024)
3.1.2 Global Dermatological Products Revenue Market Share by Players (2019-2024)
3.2 Global Dermatological Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Dermatological Products Revenue
3.4 Global Dermatological Products Market Concentration Ratio
3.4.1 Global Dermatological Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermatological Products Revenue in 2023
3.5 Dermatological Products Key Players Head office and Area Served
3.6 Key Players Dermatological Products Product Solution and Service
3.7 Date of Enter into Dermatological Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Dermatological Products Breakdown Data by Type
4.1 Global Dermatological Products Historic Market Size by Type (2019-2024)
4.2 Global Dermatological Products Forecasted Market Size by Type (2025-2030)
5 Dermatological Products Breakdown Data by Application
5.1 Global Dermatological Products Historic Market Size by Application (2019-2024)
5.2 Global Dermatological Products Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Dermatological Products Market Size (2019-2030)
6.2 North America Dermatological Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Dermatological Products Market Size by Country (2019-2024)
6.4 North America Dermatological Products Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dermatological Products Market Size (2019-2030)
7.2 Europe Dermatological Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Dermatological Products Market Size by Country (2019-2024)
7.4 Europe Dermatological Products Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dermatological Products Market Size (2019-2030)
8.2 Asia-Pacific Dermatological Products Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Dermatological Products Market Size by Region (2019-2024)
8.4 Asia-Pacific Dermatological Products Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dermatological Products Market Size (2019-2030)
9.2 Latin America Dermatological Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Dermatological Products Market Size by Country (2019-2024)
9.4 Latin America Dermatological Products Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dermatological Products Market Size (2019-2030)
10.2 Middle East & Africa Dermatological Products Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Dermatological Products Market Size by Country (2019-2024)
10.4 Middle East & Africa Dermatological Products Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Dermatological Products Introduction
11.1.4 Johnson & Johnson Revenue in Dermatological Products Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Dermatological Products Introduction
11.2.4 GSK Revenue in Dermatological Products Business (2019-2024)
11.2.5 GSK Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Dermatological Products Introduction
11.3.4 Pfizer Revenue in Dermatological Products Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Detail
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Dermatological Products Introduction
11.4.4 AbbVie Revenue in Dermatological Products Business (2019-2024)
11.4.5 AbbVie Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Dermatological Products Introduction
11.5.4 Bayer Revenue in Dermatological Products Business (2019-2024)
11.5.5 Bayer Recent Development
11.6 Merck
11.6.1 Merck Company Detail
11.6.2 Merck Business Overview
11.6.3 Merck Dermatological Products Introduction
11.6.4 Merck Revenue in Dermatological Products Business (2019-2024)
11.6.5 Merck Recent Development
11.7 Reckitt Benckiser
11.7.1 Reckitt Benckiser Company Detail
11.7.2 Reckitt Benckiser Business Overview
11.7.3 Reckitt Benckiser Dermatological Products Introduction
11.7.4 Reckitt Benckiser Revenue in Dermatological Products Business (2019-2024)
11.7.5 Reckitt Benckiser Recent Development
11.8 Taisho Pharmaceutical
11.8.1 Taisho Pharmaceutical Company Detail
11.8.2 Taisho Pharmaceutical Business Overview
11.8.3 Taisho Pharmaceutical Dermatological Products Introduction
11.8.4 Taisho Pharmaceutical Revenue in Dermatological Products Business (2019-2024)
11.8.5 Taisho Pharmaceutical Recent Development
11.9 Perrigo
11.9.1 Perrigo Company Detail
11.9.2 Perrigo Business Overview
11.9.3 Perrigo Dermatological Products Introduction
11.9.4 Perrigo Revenue in Dermatological Products Business (2019-2024)
11.9.5 Perrigo Recent Development
11.10 Ikeda Mohando
11.10.1 Ikeda Mohando Company Detail
11.10.2 Ikeda Mohando Business Overview
11.10.3 Ikeda Mohando Dermatological Products Introduction
11.10.4 Ikeda Mohando Revenue in Dermatological Products Business (2019-2024)
11.10.5 Ikeda Mohando Recent Development
11.11 DermaPharm A/S
11.11.1 DermaPharm A/S Company Detail
11.11.2 DermaPharm A/S Business Overview
11.11.3 DermaPharm A/S Dermatological Products Introduction
11.11.4 DermaPharm A/S Revenue in Dermatological Products Business (2019-2024)
11.11.5 DermaPharm A/S Recent Development
11.12 LEO Pharma
11.12.1 LEO Pharma Company Detail
11.12.2 LEO Pharma Business Overview
11.12.3 LEO Pharma Dermatological Products Introduction
11.12.4 LEO Pharma Revenue in Dermatological Products Business (2019-2024)
11.12.5 LEO Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
